Remimazolam for the prevention of emergence agitation in adults following nasal surgery under general anesthesia: a prospective randomized clinical controlled trial
Abstract Background Remimazolam is a novel intravenous sedative/anesthetic drug that belongs to the ultra-short-acting class of benzodiazepines. The purpose of this study was to evaluate the effectiveness of postoperative use of remimazolam in preventing emergence agitation (EA) in adults following...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-01-01
|
| Serija: | BMC Anesthesiology |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s12871-024-02875-1 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|